Log in

NASDAQ:CATSCatasys Stock Price, Forecast & News

0.00 (0.00 %)
(As of 07/16/2020)
Today's Range
Now: $25.89
50-Day Range
MA: $24.55
52-Week Range
Now: $25.89
Volume319,900 shs
Average Volume325,358 shs
Market Capitalization$440.65 million
P/E RatioN/A
Dividend YieldN/A
Catasys, Inc. provides big data predictive analytics, artificial intelligence and telehealth, combined with human intervention services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services. The company's OnTrak solution includes medical and psychosocial interventions; and a proprietary Web based clinical information platform and database, psychosocial programs, and integrated care coaching services. Its OnTrak solution combines medical and psychosocial treatments with elements of traditional disease management, case management, and ongoing member support to help organizations treat and manage populations struggling with substance dependence, depression, and anxiety to improve their health and thereby decrease their health care costs. Catasys, Inc.'s OnTrak solution includes various components, such as identification of impactable members, member engagement, enrollment/referral, provider network, outpatient medical treatment, outpatient psychosocial treatment, care coaching, monitoring and reporting, and proprietary Web-based clinical information platform. The company was formerly known as Hythiam, Inc. and changed its name to Catasys, Inc. in March 2011. Catasys, Inc. was founded in 2000 and is based in Los Angeles, California.
Read More
Catasys logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.35 out of 5 stars

Industry, Sector and Symbol

Industry Miscellaneous health & allied services, not elsewhere classified
Current SymbolNASDAQ:CATS
Previous SymbolOTCMKTS:CATS



Sales & Book Value

Annual Sales$35.10 million
Book Value($1.44) per share


Net Income$-25,660,000.00


Market Cap$440.65 million
Next Earnings Date8/12/2020 (Estimated)
OptionableNot Optionable
0.00 (0.00 %)
(As of 07/16/2020)
30 days | 90 days | 365 days | Advanced Chart

Receive CATS News and Ratings via Email

Sign-up to receive the latest news and ratings for CATS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Catasys (NASDAQ:CATS) Frequently Asked Questions

How has Catasys' stock been impacted by COVID-19 (Coronavirus)?

Catasys' stock was trading at $13.17 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CATS shares have increased by 96.6% and is now trading at $25.89.
View which stocks have been most impacted by Coronavirus

Do Wall Street analysts recommend investors buy shares of Catasys?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Catasys in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Catasys

When is Catasys' next earnings date?

Catasys is scheduled to release its next quarterly earnings announcement on Wednesday, August 12th 2020.
View our earnings forecast for Catasys

How were Catasys' earnings last quarter?

Catasys, Inc. (NASDAQ:CATS) announced its earnings results on Thursday, May, 7th. The company reported ($0.45) EPS for the quarter, missing analysts' consensus estimates of ($0.41) by $0.04. The company had revenue of $12.34 million for the quarter.
View Catasys' earnings history

What guidance has Catasys issued on next quarter's earnings?

Catasys issued an update on its FY 2020 After-Hours earnings guidance on Thursday, May, 7th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $90 million, compared to the consensus revenue estimate of $87.31 million.

What price target have analysts set for CATS?

2 equities research analysts have issued twelve-month price objectives for Catasys' stock. Their forecasts range from $26.00 to $35.00. On average, they expect Catasys' share price to reach $30.50 in the next twelve months. This suggests a possible upside of 17.8% from the stock's current price.
View analysts' price targets for Catasys

Has Catasys been receiving favorable news coverage?

News headlines about CATS stock have been trending negative this week, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Catasys earned a media sentiment score of -2.8 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future.
View the latest news about Catasys

Who are some of Catasys' key competitors?

What other stocks do shareholders of Catasys own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Catasys investors own include Inseego (INSG), NVIDIA (NVDA), Alibaba Group (BABA), Micron Technology (MU), BioXcel Therapeutics (BTAI), Cisco Systems (CSCO), Alteryx (AYX), Canopy Growth (CGC), Crispr Therapeutics (CRSP) and Inovio Pharmaceuticals (INO).

Who are Catasys' key executives?

Catasys' management team includes the following people:
  • Mr. Terren S. Peizer, Founder, Chairman & CEO (Age 59)
  • Mr. Richard A. Anderson, Pres & COO (Age 50)
  • Mr. Christopher L. Shirley, Chief Financial Officer (Age 43)
  • Mr. Michael E. Green, Director of Bus. Devel.
  • Mr. Jeremiah Stone, Chief Technology Officer

What is Catasys' stock symbol?

Catasys trades on the NASDAQ under the ticker symbol "CATS."

Who are Catasys' major shareholders?

Catasys' stock is owned by many different institutional and retail investors. Top institutional investors include Janney Montgomery Scott LLC (0.87%), Taylor Wealth Management Partners (0.52%), Baldwin Brothers Inc. MA (0.19%), QV Investors Inc. (0.06%), UBS Group AG (0.03%) and SG Americas Securities LLC (0.03%). Company insiders that own Catasys stock include Curtis Medeiros and David E Smith.
View institutional ownership trends for Catasys

Which institutional investors are selling Catasys stock?

CATS stock was sold by a variety of institutional investors in the last quarter, including Janney Montgomery Scott LLC, UBS Group AG, and Taylor Wealth Management Partners.
View insider buying and selling activity for Catasys

Which institutional investors are buying Catasys stock?

CATS stock was acquired by a variety of institutional investors in the last quarter, including QV Investors Inc., SG Americas Securities LLC, and Baldwin Brothers Inc. MA.
View insider buying and selling activity for Catasys

How do I buy shares of Catasys?

Shares of CATS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Catasys' stock price today?

One share of CATS stock can currently be purchased for approximately $25.89.

How big of a company is Catasys?

Catasys has a market capitalization of $440.65 million and generates $35.10 million in revenue each year. The company earns $-25,660,000.00 in net income (profit) each year or ($1.15) on an earnings per share basis.

What is Catasys' official website?

The official website for Catasys is www.catasys.com.

How can I contact Catasys?

Catasys' mailing address is 11601 WILSHIRE BOULEVARD SUITE 1100, LOS ANGELES CA, 90025. The company can be reached via phone at 310-444-4300 or via email at [email protected]

This page was last updated on 8/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.